Enhanced BK-induced calcium responsiveness in PC12 cells expressing the C100 fragment of the amyloid precursor protein

Molecular Brain Research

Volumn 72, Issue 2, 1999, Pages 205-213

  Pascale, Alessia ^a   Bhagavan, Seetha ^a   Nelson, Thomas J ^b   Neve, Rachael L ^c   McPhie, Donna L ^c   Etcheberrigaray, René ^a  

^a Georgetown Inst Cogn Compl Sci   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Bradykinin; C100; Calcium; PC12

Indexed keywords

AMYLOID PRECURSOR PROTEIN; BRADYKININ; CALCIUM; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; ION CHANNEL;

ALZHEIMER DISEASE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CELL STRAIN; CONCENTRATION RESPONSE; HUMAN; HUMAN CELL; NERVE DEGENERATION; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; PROTEIN SECRETION;

ANIMALIA; HERPES; SIMPLEXVIRUS;

EID: 0032850283     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(99)00223-5     Document Type: Article

References (56)

1. Arispe N., Pollard H.B., Rojas E. Giant multilevel cation channels formed by Alzheimer disease amyloid β-protein [Aβ (1-40)] in bilayer membranes. Proc. Natl. Acad. Sci. U.S.A. 90:1993;10573-10577.
2. Benedetti A., Fulceri R., Romani A., Comporti M. Mg ATP-dependent glucose 6-phosphate stimulated Ca accumulation in liver microsomal fractions. J. Biol. Chem. 263:1988;3466-3473.
3. J. Berger-Sweeney, D.L. McPhie, J.A. Arters, J. Greenan, M.L. Oster-Granite, R.L. Neve, Impairment in spatial learning accompanied by neurodegeneration in mice transfenic for the carboxyl-terminus of the amyloid precursor protein, Mol. Brain Res., in press.
4. Borchelt D.R., Thinakaran G., Eckman C.B., Lee M.K., Davenport F., Ratovisky T., Prada C.-M., Kim G., Seekins S., Yager D., Slunt H.H., Wang R., Seeger M., Levey A.I., Gandy S.E., Copeland N.G., Jenkins N.A., Price D.L., Younkins S.G., Sisodia S.S. Familial Alzheimer's disease-linked presenilin 1 variants elevate Aβ 1-42/1-40 ratio in vitro and in vivo. Neuron. 17:1996;1005-1013.
5. Cai X.-D., Golde T.E., Younkin S.G. Release of excess amyloid protein from a mutant amyloid protein precursor. Science. 259:1993;514-516.
6. Citron M., Vigo-Pelfrey C., Teplow D.B., Miller C., Schenk D., Johnston J., Winblad B., Venizelos N., Lanfelt L., Selkoe D.J. Excessive production of β-amyloid protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation. Proc. Natl. Acad. Sci. U.S.A. 91:1994;11993-11997.
7. Citron M., Teplow D.B., Selkoe D.J. Generation of amyloid β-protein from its precursor is sequence specific. Neuron. 14:1995;661-670.
8. Davis-Salinas J., Saporito-Irwin S.M., Cotman C.W., Van Nostrand W.E. Amyloid β-protein induces its own production in cultured degenerating cerebrovascular smooth muscle cells. J. Neurochem. 65:1995;931-934.
9. Eckert A., Hartmann H., Förstl H., Müller W.E. Alterations of intracellular calcium regulation during aging and Alzheimer's disease in nonneural cells. Life Sciences. 55:1994;2019-2029.
10. + channels. Science. 264:1994;276-279.
11. Fraser S.P., Suh Y.-H., Chong Y.H., Djamgoz M.B.A. Membrane currents induced in Xenopus oocytes by the C-terminal fragment of the β-amyloid precursor protein. J. Neurochem. 66:1996;2034-2040.
12. Fraser S.P., Suh Y.-H., Andamgoz M.B.A. Ionic effects of the Alzheimer's disease β-amyloid precursor protein and its metabolic fragments. Trends Neurosci. 20:1997;67-72.
13. Fukuchi K., Sopher B., Furlong C.E., Smith A.C., Dang N.T., Martin G.M. Selective neurotoxicity of the COOH-terminal fragments of the β-amyloid precursor protein. Neurosci. Lett. 154:1993;145-148.
14. Fulceri R., Nori A., Gamberucci A., Bolpe P., Giunti R., Benedetti A. Fatty acetyl-CoA esters induce calcium release from terminal cisternae of skeletal muscle. Cell Calcium. 15:1994;109-116.
15. Furukawa K., Abe Y., Akaike N. Amyloid protein-induced irreversible current in rat cortical neurones. NeuroReport. 5:1994;2016-2018.
16. Gandy S., Greengard P. Processing of Alzheimer Aβ-amyloid precursor protein: cell biology, regulation, and role in Alzheimer disease. Int. Rev. Neurobiol. 36:1994;29-50.
17. Gibson G.E., Vestling M., Zhang H., Szolosi S., Alkon D.L., Lannfelt L., Gandy S., Cowburn R.F. Abnormalities in Alzheimer s disease fibroblasts bearing the APP670/671 mutation. Neurobiol. Aging. 18:1997;573-580.
18. + current in rat hippocampal neurons. Biophys. J. 70:1996;296-304.
19. Hardy J. Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci. 20:1997;154-159.
20. Hirashima N., Etcheberrigaray R., Bergamaschi S., Racchi M., Battaini F., Binetti G., Govoni S., Alkon D.L. Calcium responses in human fibroblasts: a diagnostic molecular profile for Alzheimer's disease. Neurobiol. Aging. 17:1996;549-555.
21. Huang H.-M., Lin T.-A., Sun G.Y., Gibson G.E. Increased inositol 1,4,5-triphosphate accumulation correlates with an up-regulation of bradykinin receptors in Alzheimer's disease. J. Neurochem. 64:1995;761-766.
22. 2+ mobilization in fibroblasts from patients with Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 91:1994;534-538.
23. Johnston J.A., Cowburn R.F., Norgren S., Wiehager B., Venizelos N., Winblad B., Vigo-Pelfrey C., Schenk D., Lanfelt L., O'Neill C. Increased β-amyloid release and levels of amyloid precursor protein (APP) in fibroblasts cell lines from family members with the Swedish Alzheimer's disease APP670/671 mutation. FEBS Letters. 354:1994;274-278.
24. Kim S.-H., Suh Y.-H. Neurotoxicity of a carboxyl-terminal fragment of the Alzheimer's amyloid precursor protein. J. Neurochem. 67:1996;1172-1182.
25. Kim H.J., Suh Y.H., Lee M.H., Ryu P.D. C-terminal fragment of the β-amyloid precursor protein forms cation selective channels in planar lipid bilayers. Soc. Neurosci. Abstr. 22:1996;2110.
26. Khachaturian Z.S. Calcium Hypothesis of Alzheimer's disease and brain aging. Ann. N.Y. Acad. Sci. 747:1994;1-11.
27. Kozlowski M.R., Spanoyannis A., Manly S.P., Fidel S.A., Neve R.L. The neurotoxic carboxyl-terminal fragment of the Alzheimer amyloid precursor binds specifically to a neuronal cell surface molecule: pH dependence of the neurotoxicity and the binding. J. Neurosci. 12:1992;1679-1687.
28. Luo Y.Q., Hirashima N., Li Y.H., Alkon D.L., Sunderland T., Etcheberrigaray R., Wolozin B. Physiological levels of β-amyloid increases tyrosine phosphorylation and cytosolic calcium. Brain Res. 681:1995;65-74.
29. Maruyama K., Terakado K., Usami M., Yoshikawa K. Formation of amyloid-like fibrils in COS cells overexpressing part of the Alzheimer amyloid protein precursor. Nature. 347:1990;566-569.
30. M.P. Mattson, K. Furukawa, A.J. Bruce, R.J. Mark, E. Blanc, Calcium homeostasis and free radical metabolism as convergence points in the pathophysiology of dementia, in: W. Wasco, R.E. Tanzi (Eds.), Molecular Mechanisms of Dementia, Humana Press, Totowa, New Jersey, 1997, pp. 103-143.
31. Mattson M.P. Calcium and neuronal injury in Alzheimer's disease. Ann. N.Y. Acad. Sci. 747:1994;50-76.
32. 2+ homeostasis in Alzheimer's disease. Trends Neurosci. 16:1993;409-414.
33. Maury C.P.J. Molecular pathogenesis of β-amyloidosis in Alzheimer's disease and other cerebral amyloidoses. Laboratory Investigation. 72:1995;4-16.
34. McPhie D.L., Lee R.K.K., Eckman C.B., Olstein D.H., Durham S.P., Yager D., Younkin S.G., Wurtman R.J., Neve R.L. Neuronal expression of β-amyloid precursor protein Alzheimer mutations causes intracellular accumulation of a C-terminal fragment containing both the amyloid and cytoplasmic domains. J. Biol. Chem. 272:1997;24743-24746.
35. Mirzabekov T., Lin M.-ch., Youan W.-l., Marshal P.J., Carman M., Tomaselli K., Lieberburg I., Kagan B.L. Channel formation in planar lipid bilayers by a neurotoxic fragment of the beta-amyloid peptide. Biochem. Biophys. Res. Commun. 202:1994;1142-1148.
36. H. Motulksy, Intuitive Biostatistics, Oxford Univ. Press, New York, 1995.
37. Nalbantoglu J., Tirado-Santiago G., Lahsaini A., Poirier J., Goncalves O., Verge G., Momoli F., Weiner S.A., Massicotte G., Julien J.-P., Shapiro M.L. Impaired learning and LTP in mice expressing the carboxy terminus of the Alzheimer amyloid precursor protein. Nature. 387:1997;500-505.
38. Neve R.L., Kammessheidt A., Hohmann C.F. Brain transplants of cells expressing the carboxyl-terminal fragment of the Alzheimer amyloid protein precursor cause specific neuropathology in vivo. Proc. Natl. Acad. Sci. U.S.A. 89:1992;3448-3452.
39. Neve R.L., Boyce F.M., McPhie D.L., Greenan J., Oster-Granite M.L. Transgenic mice expressing APP-C100 in the brain. Neurobiol. Aging. 17:1996;191-203.
40. Oster-Granite M.L., McPhie D.L. Age-dependent neuronal and synaptic degeneration in mice transgenic for the C terminus of the amyloid precursor protein. J. Neurosci. 16:1996;6732-6741.
41. Pike C.J., Walencewicz A.J., Glabe C.G., Cotman C.W. In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res. 563:1991;311-314.
42. Pike C.J., Burdick D., Walencewicz A.J., Glabe C.G., Cotman C.W. Neurodegeneration induced by β-amyloid peptides in vitro: the role of peptide assembly state. J. Neurosci. 13:1993;1676-1687.
43. Pike C.J., Cummings B.J., Monzavi R., Cotman C.W. β-amyloid-induced changes in cultured astrocytes parallel reactive astrocytosis associated with senile plaques in Alzheimer's disease. Neuroscience. 63:1994;517-531.
44. Scheuner D., Eckman C., Jensen M., Song X., Citron M., Suzuki N., Bird T.D., Hardy J., Hutton M., Kukull W., Larson E., Levy-Lahad E., Viitanen M., Peskind E., Poorkaj P., Schellenberg G., Tanzi R., Wasco W., Lannfelt L., Selkoe D., Younkin S. Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat. Med. 22:1996;864-870.
45. Selkoe D.J. Normal and abnormal biology of the β-amyloid precursor protein. Annu. Rev. Neurosci. 17:1994;489-517.
46. Selkoe D.J. Alzheimer's disease: genotypes, phenotype and treatments. Science. 275:1997;630-631.
47. Sheehan J.P., Swerdlow R.H., Miller S.W., Davis R.E., Parks J.K., Parker W.D., Tuttle J.B. Calcium homeostasis and reactive oxygen species production in cells transformed by mitochondria from individuals with sporadic Alzheimer's disease. J. Neurosci. 17:1997;4612-4622.
48. Suh Y.-H. An etiological role of amyloidogenic carboxyl-terminal fragments of the β-amyloid precursor protein in Alzheimer's disease. J. Neurochem. 68:1997;1781-1791.
49. 717) mutants. Science. 264:1994;1336.
50. Takemura H., Hughes A.R., Thastrup O., Putney J.W. Activation of calcium entry by the tumor promoter thapsigargin in parotid acinar cells. J. Biol. Chem. 264:1989;12266-12271.
51. Tanzi R.E., Kovacs D.M., Kim T.-W., Moir R.D., Guenette S.Y., Wasco W. The gene defects responsible for familial Alzheimer's disease. Neurobiol. Dis. 3:1996;159-168.
52. A.P. Thomas, F. Delaville, in: J.G. McCormack, P.H. Cobbold (Eds.), Cellular Calcium, IRL Press, 1991, pp. 1-54.
53. Wolf D., Quon D., Wang Y., Cordell B. Identification and characterization of C-terminal fragments of the β-amyloid precursor produced in cell culture. EMBO J. 9:1990;2079-2084.
54. Yankner B. Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron. 16:1996;921-932.
55. Yankner B.A., Dawes L.R., Fisher S., Villa-Komaroff L., Oster-Granite M.L., Neve R.L. Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science. 245:1989;417-420.
56. Yankner B.A., Duffy L.K., Kirschener D.A. Neurotrophic and neurotoxic effects of amyloid protein: reversal by tachykinin neuropeptides. Science. 250:1990;279-283.